new technologies competing with glp-1 medications 2025 Market Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 Eli Lilly telehealth partners continue
Description
PlexusDx supports personalized evaluation by combining biomarker context, genetic predisposition screening, and compounded medication options with healthcare provider guidance
View our Privacy Policy and Cookie Notice for further details
In a recent paper in The New England Journal of Medicine, physician Amanda Banks noted that the proportion of GLP-1 prescriptions written for people who were not diabetic, obese, or overweight increased from 4.5% in 2018 to 17% in 2023
But the muscle didn't
Because Pendulum aims to increase GLP-1 production, it could theoretically enhance the blood sugar lowering effects of insulin, sulfonylureas, and other diabetes medications
